The role of 99mTc-tetrofosmin scintigraphy for staging patients with laryngeal cancer

Cancer Biotherapy and Radiopharmaceuticals

Volumn 20, Issue 1, 2005, Pages 27-35

  Fattori, Bruno ^a   Grosso, Mariano ^a   Nacci, Andrea ^a   Bianchi, Francesca ^a   Cosottini, Mirco ^a   Ursino, Francesco ^a   Manca, Gianpiero ^a   Rubello, Domenico ^b   Strauss, H William ^c   Mariani, Giuliano ^a  

^a UNIVERSITY OF PISA   (Italy)

^b S MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

99mTc tetrofosmin scintigraphy; Laryngeal cancer; Staging

Indexed keywords

TETROFOSMIN TC 99M; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ESOPHAGUS SCINTISCANNING; EVALUATION; FEMALE; HUMAN; IMAGING SYSTEM; INTERMETHOD COMPARISON; LARYNX CANCER; MALE; MEDIASTINUM; NECK; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA; IMAGE PROCESSING; LARYNX TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LARYNGEAL NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 20144387511     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2005.20.27     Document Type: Article

References (35)

1. Nakayama M, Brandenburg JH. Clinical underestimation of laryngeal cancer. Predictive indicators. Arch Otolaryngol Head Neck Surg 1993;119:950.
2. van den Brekel MW, Castelijns JA, Snow GB. Diagnostic evaluation of the neck. Otolaryngol Clin N Am 1998;31:601.
3. Zbaren P, Becker M, Lang H. Staging of laryngeal cancer: Endoscopy, computed tomography, and magnetic resonance versus histopathology. Eur Arch Otolaryngol 1997;254(Suppl 1):117.
4. Zbaren P, Becker M, Lang H. Pretherapeutic staging of laryngeal carcinoma. Clinical findings, computed tomography, and magnetic resonance imaging compared with histopathology. Cancer 1996;77:1263.
5. Amilibia E, Juan A, Nogues J, et al. Neoplastic invasion of laryngeal cartilage: Diagnosis by computed tomography. Acta Otorrinolaringol Esp 2001:52:207.
6. Ayache S, Tramandinoli E, Tramier B, et al. Comparison of laryngoscopy and CT-scan results before partial laryngectomy. Ann Otolaryngol Chir Cervicofac 2003;120:271.
7. Horowitz BL, Woodson GE, Bryan RN. CT of laryngeal tumors. Radiol Clin N Am 1984;22:265.
8. Becker M, Zbaren P, Lang H, et al. Neoplastic invasion of the laryngeal cartilage: Comparison of MR imaging and CT with histopathologic correlation. Radiology 1995;194:661.
9. Williams DW III. Imaging of laryngeal cancer. Otolaryngol Clin N Am 1997;30:35.
10. Mukherji SK, Castillo M, Huda W, et al. Comparison of dynamic and spiral CT for imaging of the glottic larynx. J Comput Assist Tomogr 1995;19:899.
11. Korkmaz H, Cerezci NG, Akmansu H, et al. A comparison of spiral and conventional, computerized tomography methods in diagnosing various laryngeal lesions. Eur Arch Otorhinolaryngol 1998;255:149.
12. 18F-FDG-PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998;25:1255.
13. Myers LL, Wax MK, Williams D III, et al. Use of positron emission tomography in the evaluation of the NO neck. Laryngoscope 1998;108:232.
14. Daisne JF, Duprez T, Weynand B, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: Comparison at CT, MR imaging, and FDG-PET and validation with surgical specimen. Radiology 2004;233:93.
15. Greven KM, Williams D III, Keyes JJ, et al. Can positron emission tomography distinguish tumor recurrence from irradiation sequele in patients treated for larynx cancer? Cancer J Sci Am 1997;3:353.
16. Lowe V, Dunphy F, Varvares M, et al. Evaluation of chemotherapy response in patients with advanced head and neck cancer using FDG-PET. Head Neck 1997;19:666.
17. Minn H, Lapela M, Klemi PJ. Prediction of survival with FDG-PET in head and neck cancer. J Nucl Med 1997;38:1907.
18. Mansi L, Rambaldi PF, Procaccini E, et al. Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Eur J Nucl Med 1996;23:932.
19. Haugen BR, Lin EC. Isotope imaging for metastatic thyroid cancer. Endocrinol Metab Clin N Am 2001;30:469.
20. Casara D, Rubello D, Saladini G. Role of scintigraphy with tumor-seeking agents in the diagnosis and preoperative staging of malignant thyroid nodules. Biomed Pharmacother 2000;54:334.
21. Giordano A, Rubello D, Casara D. New trends in parathyroid scintigraphy. Eur J Nucl Med 2001;28:1409.
22. 99mTc-tetrofosmin scintigraphy in lung carcinoma staging and follow-up evaluations. Cancer 2002;94:1796.
23. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J Nucl Med 1990;31:1646.
24. Younes A, Songdale JA, Maublant J, et al. Mechanism of uptake of technetium-tetrofosmin. II: Uptake into isolated adult rat heart mitochondria. J Nucl Cardiol 1995;2:327.
25. Nakamura K, Sammiya T, Hashimoto J, et al. Comparison of cationic myocardial perfusion agents: Characteristics of accumulation in cultured smooth muscle cells. Ann Nucl Med 1996;10:375.
26. Crankshaw CL, Marmion M, Luker GD, et al. Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein. J Nucl Med 1998;39:77.
27. 99m- tetrofosmin, Technetium-99m-MIBI, and thallium-201 uptake in rat myocardial cells. J Nucl Med 1998;39:266.
28. 99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumor cell line. Eur J Nucl Med 2000;27:1786.
29. Shiau YC, Tsai SC, Wang JJ, et al. Detection of cervical lymph node metastases of nasopharyngeal carcinomas with technetium-99m tetrofosmin single photon emission computed tomography and comparison with computed tomography. Anticancer Res 2001;21(1B): 723.
30. Antonelli A, Miccoli P, Ferdeghini M, et al. Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer. Thyroid 1995;5:25.
31. Kau RJ, Alexiou C, Stimmer H, et al. Diagnostic procedures for detection of lymph node metastases in cancer of the larynx. ORL J Otorhinolaryngol Relat Spec 2000;62:199.
32. 99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma. Eur J Nucl Med 1997;24:621.
33. Muzzammil T, Moore MJ, Ballinger JR. In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumors. Cancer Biother Radiopharm 2000;15:339.
34. Sun SS, Hsieh JF, Tsai SC, et al. Technetium-99m tetrofosmin mammoscintigraphy findings related to the expression of P-glycoprotein-mediated multidrug resistance. Anticancer Res 2000;20(3A):1467.
35. Marian T, Szabo G, Goda K, et al. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance. Eur J Nucl Med Mol Imaging 2003;30:1147.